Jakavi (ruxolintib)

pCPA File Number: 20905
Negotiation Status:
Concluded with an LOI
Indication(s):
Polycythemia vera
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PC0065-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: